TipRanks
Advertisement

DIVB - ETF AI Analysis

Compare

Top Page

DIVB

iShares U.S. Dividend & Buyback ETF (DIVB)

Rating:72Outperform
Price Target:―
DIVB, the iShares U.S. Dividend & Buyback ETF, has an overall rating that suggests it is a solid but not flawless choice for investors seeking companies that return cash through dividends and buybacks. Strong holdings like Accenture, IBM, Cognizant, Johnson & Johnson, and Exxon Mobil support the fund’s quality by combining robust financial performance, strategic focus on AI and technology, and generally positive earnings sentiment. However, names like HP and AbbVie introduce some drag due to financial stability, operational efficiency, and valuation concerns, and the fund’s tilt toward large, established U.S. companies in sectors like technology, financials, and energy means investors should be aware of sector and U.S.-market concentration risk.
Positive Factors
Strong Recent Performance
The ETF has shown strong gains over the year and in recent months, indicating solid momentum.
Low Expense Ratio
The fund’s very low fee means more of the returns stay in investors’ pockets instead of going to costs.
Broad Sector Diversification
Holdings spread across technology, financials, health care, energy, and other sectors help reduce the impact of weakness in any single industry.
Negative Factors
Underperforming Top Holdings
Several of the largest positions, including major technology and consulting names, have shown weak performance this year, which can drag on the fund.
Heavy U.S. Concentration
Almost all assets are invested in U.S. companies, offering very limited geographic diversification outside the United States.
Tilt Toward Technology Sector
A large allocation to technology stocks increases the fund’s sensitivity to downturns or volatility in that sector.

DIVB vs. SPDR S&P 500 ETF (SPY)

DIVB Summary

The iShares U.S. Dividend & Buyback ETF (DIVB) tracks the Morningstar US Dividend and Buyback Index, focusing on U.S. companies that both pay dividends and buy back their own shares. It holds a mix of well-known names like JPMorgan Chase, Exxon Mobil, Johnson & Johnson, and IBM, spread across sectors such as technology, finance, health care, and energy. Someone might invest in this ETF to seek a blend of income and long-term growth from a broad group of established companies. A key risk is that it still moves with the overall stock market, so its value can rise and fall over time.
How much will it cost me?The iShares U.S. Dividend & Buyback ETF (DIVB) has an expense ratio of 0.05%, meaning you’ll pay $0.50 per year for every $1,000 invested. This is lower than average because it’s a passively managed fund that tracks an index, which typically has lower costs compared to actively managed funds.
What would affect this ETF?The iShares U.S. Dividend & Buyback ETF (DIVB) could benefit from strong corporate earnings and shareholder-friendly strategies like buybacks and dividends, particularly in sectors like Technology and Financials, which make up a significant portion of its holdings. However, rising interest rates or economic slowdowns could negatively impact dividend-paying companies and sectors like Consumer Defensive and Industrials, while regulatory changes in the U.S. could also pose challenges. The ETF’s focus on U.S. equities means its performance is closely tied to the health of the U.S. economy and market conditions.

DIVB Top 10 Holdings

DIVB leans heavily into U.S. tech and business services, with giants like ADP, IBM, and Accenture sitting near the top. Lately, these consulting and IT names have been a bit of a headwind, with Paychex also lagging and tugging on returns. On the brighter side, Exxon Mobil has been rising with energy strength, while HP, Johnson & Johnson, and AbbVie are providing a steadier, supportive backdrop. Overall, it’s a U.S.-focused, shareholder-return story, but recent softness in its tech and services core has dulled some of the shine.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Accenture5.40%$107.31M$118.35B-23.55%
79
Outperform
International Business Machines4.88%$96.93M$208.48B-23.55%
79
Outperform
Automatic Data Processing4.83%$96.08M$103.96B-9.75%
70
Outperform
Cognizant2.90%$57.70M$25.77B-15.78%
79
Outperform
Exxon Mobil2.64%$52.39M$676.33B44.26%
74
Outperform
JPMorgan Chase2.55%$50.71M$880.60B8.96%
72
Outperform
HP2.25%$44.65M$28.61B17.39%
61
Neutral
Johnson & Johnson2.06%$40.96M$613.99B34.31%
78
Outperform
Paychex2.01%$40.00M$35.96B-20.47%
77
Outperform
AbbVie1.91%$38.01M$471.27B14.54%
66
Neutral

DIVB Technical Analysis

Technical Analysis Sentiment
Positive
Last Price―
Price Trends
50DMA
67.04
Negative
100DMA
64.40
Positive
200DMA
59.44
Positive
Market Momentum
MACD
-0.53
Positive
RSI
51.35
Neutral
STOCH
61.11
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For DIVB, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 66.18, equal to the 50-day MA of 67.04, and equal to the 200-day MA of 59.44, indicating a neutral trend. The MACD of -0.53 indicates Positive momentum. The RSI at 51.35 is Neutral, neither overbought nor oversold. The STOCH value of 61.11 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DIVB.

DIVB Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
――$1.99B0.05%
72
Outperform
――$9.60B0.02%
74
Outperform
――$5.63B0.25%
74
Outperform
――$5.33B0.50%
75
Outperform
――$4.97B0.06%
73
Outperform
――$4.65B0.34%
74
Outperform
Performance Comparison
Ticker
Company Name
Price
Change
% Change
DIVB
iShares U.S. Dividend & Buyback ETF
66.32
15.66
30.91%
BBUS
JP Morgan Betabuilders U.S. Equity ETF
―
―
―
DSI
iShares MSCI KLD 400 Social ETF
―
―
―
QLTY
GMO U.S. Quality ETF
―
―
―
VTHR
Vanguard Russell 3000 ETF
―
―
―
TSPA
T. Rowe Price U.S. Equity Research ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement